2021
DOI: 10.1016/j.ces.2021.116497
|View full text |Cite
|
Sign up to set email alerts
|

Strategy to equivalence testing for development and scale up of biopharmaceutical downstream processes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
0
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 18 publications
0
0
0
Order By: Relevance
“…δ is a hypothetical value such that if the absolute value of the observed difference is no more than δ, there is a strong probability of concluding that the two datasets represent equivalent results [40]. There are different methods to calculate the equivalence acceptance criterion [36], such as the 3-sigma rule (the one used in this paper), Limentani's EAC, Limentani modified, Cohen's standardized difference-effect sizes-and tolerance interval.…”
Section: Tensile Strength Eacmentioning
confidence: 99%
See 2 more Smart Citations
“…δ is a hypothetical value such that if the absolute value of the observed difference is no more than δ, there is a strong probability of concluding that the two datasets represent equivalent results [40]. There are different methods to calculate the equivalence acceptance criterion [36], such as the 3-sigma rule (the one used in this paper), Limentani's EAC, Limentani modified, Cohen's standardized difference-effect sizes-and tolerance interval.…”
Section: Tensile Strength Eacmentioning
confidence: 99%
“…Today, a simple equivalence test first introduced by Schuirmann et al [37] is accepted, for example, as standard for bioequivalence assessment [38], namely, the two one-sided t-test (TOST). In contrast to the two-sample t-test, the null hypothesis of the TOST states that the two means are not equivalent [36]. The impact of the null hypothesis is that in the case of small sample sizes and/or poor precision (large variance) in one or both groups, equivalence is rejected, resulting in low numbers of false-positive test results [39].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation